Over the course of Super Bowl week, the Dallas Cowboys have been front and center for a whole lot of juicy chatter. And, after all, isn't that what Super Bowl week is for? It's a week where thousands ...
Hosted on MSN
‘Bottom of the pile’ – Arteta told to drop ‘embarrassing’ Arsenal player after win over Chelsea
Arsenal boss Mikel Arteta has been urged to drop Viktor Gyokeres after his “embarrassing” performance against Chelsea on Tuesday night. Kai Havertz scored the only goal of the game in the seventh ...
Kalvin Phillips was considered by Manchester United before joining Sheffield United. Despite potential interest from Ole Gunnar Solskjaer and coaching staff, data analysts were not keen on the ...
But there can’t be heroes without some peril to overcome. Sometimes that peril is created in exciting fashion, too. We just ...
Justine Kraemer is a Senior List Writer at Collider and a freelance writer based in Ontario, Canada. She is passionate about finding new angles on the latest movies and TV shows. With over five years ...
After starting seven games as a freshman wide receiver, Raiden Vines-Bright left the University of Washington football team and went home, which was a bit of a surprise in Montlake. After all, he ...
In the aftermath of every Super Bowl, we talk about the game and the halftime show, but we’re also eager to discuss the ...
Lane Kiffin and Co. are putting a foot on the gas for the elite defensive back, labeled team to beat as recruitment heats up. The LSU Tigers are building momentum on the recruiting trail following a ...
Josh Cotts is a Senior Contributor at GameRant. He graduated Summa Cum Laude from Arizona State University in 2019 with a B.A. in Mass Communications & Media Studies and has been recognized for his ...
Indiana had barely finished celebrating Monday night when college football's next season quietly began. The Hoosiers' first national championship -- and the Big Ten's third straight -- closed one ...
Teva Pharmaceutical (TEVA) traded lower in the premarket on Wednesday after the generic drugmaker projected lower-than-expected financials for 2026 and a contraction in its business even as its Q4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results